Sandoz Hits Back At Biosimilar Misinformation

Global Biopharma Head Insists That “Biosimilar Information Battle” Will Be Won

 
• By David Wallace
  
Fake News
Sandoz has hit back at falsehoods and misleading claims around biosimilars • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products